胸腺基质淋巴细胞生成素在脓毒症患者血清中的表达及临床意义
2021-05-06陈晶莹罗惠君何文成张卫星罗华张声
陈晶莹 罗惠君 何文成 张卫星 罗华 张声



【摘要】 目的:探討胸腺基质淋巴细胞生成素(Thymic stromal lymphopoietin,TSLP)在脓毒症患者血清中的表达及临床意义。方法:收集2017年1月-2019年10月在本院ICU住院治疗的患者80例为研究对象,共分三组,对照组(C组,n=30),脓毒症组(S组,n=30),脓毒症休克组(SS组,n=20)。采集所有研究对象入ICU后24 h内的临床资料、检查结果及空腹静脉血5 mL,用双抗体夹心酶联免疫吸附法(ELISA)测定血清TSLP,IL-6的浓度,分析两者在脓毒症患者中的表达及相关性。结果:与C组
患者相比,S组及SS组患者在性别构成、年龄、APACHEⅡ评分、白细胞计数上差异均无统计学意义(P>0.05);S组患者血清PCT浓度与C组比较,差异无统计学意义(P>0.05);SS组患者血清PCT浓度显著高于C组及S组,差异均有统计学意义(P<0.000 1)。S组患者血清TSLP的浓度显著高于C组(P<0.000 1),
IL-6的浓度高于C组(P=0.030)。SS组患者血清TSLP高于S组(P=0.010),IL-6的浓度显著高于S组(P<0.000 1)。S组患者血清中TSLP的浓度与IL-6的浓度呈明显正相关(r=0.61,P<0.01)。结论:TSLP在脓毒症患者血清中表达增高,且与脓毒症的严重程度相关,提示TSLP参与脓毒症的发病机制。
【关键词】 脓毒症 脓毒症休克 胸腺基质淋巴细胞生成素
Expression and Clinical Significance of Thymic Stromal Lymphopoietin in Serum of Patients with Sepsis/CHEN Jingying, LUO Huijun, HE Wencheng, ZHANG Weixing, LUO Hua, ZHANG Sheng. //Medical Innovation of China, 2021, 18(07): -118
[Abstract] Objective: To investigate the expression and clinical significance of thymic stromal Lymphopoietin (TSLP) in serum of patients with sepsis. Method: Eighty patients admitted to ICU of our hospital from January 2017 to October 2019 were selected and divided into three groups: control group (group C, n=30), septic group (group S, n=30) and septic shock group (group SS, n=20). Clinical and examination data and 5 mL venous blood of the patients were collected within 24 hours after be admitted to ICU. The serum levels of TSLP and IL-6 were measured by double antibody sandwich enzyme linked immunosorbent assay (ELISA). The expressions and correlation of TSLP and IL-6 in septic patients were analyzed. Result: Compared with group C, there were no significant differences in gender composition, age, APACHEⅡ score and white blood cell count between group S and group SS (P>0.05); there was no significant difference in serum PCT concentration between group S and group C (P>0.05); the serum PCT concentration in group SS was significantly higher than that in group C and group S (P<0.000 1). The concentration of serum TSLP in group S was significantly higher than that in group C (P<0.000 1),
and the concentration of IL-6 in group S was higher than that in group C (P=0.030). The serum TSLP of group SS was higher than that of group S (P=0.010), and the concentration of IL-6 was significantly higher than that of group S (P<0.000 1). There was a positive correlation between TSLP and IL-6 in group S (r=0.61, P<0.01). Conclusion: The expression of TSLP in the serum of patients with sepsis is increased and related to the severity of sepsis, which suggests that TSLP may be involved in the pathogenesis of sepsis.
[Key words] Sepsis Septic shock Thymic stromal lymphopoietin
First-authors address: Peking University Shenzhen Hospital, Shenzhen 518035, China
doi:10.3969/j.issn.1674-4985.2021.07.028
脓毒症是由宿主对感染的反应失调,引起的一系列病理、生理和生化异常,导致危及生命的器官功能障碍[1],全世界每年约有530万人死于脓毒症[2],是一个严重危及公共健康的问题,其患病率及死亡率极高,是一种异质性综合征[3],发病机制尚未明确。胸腺基质淋巴细胞生成素(Thymic stromal lymphopoietin,TSLP)是白介素-2细胞因子家族的一员,1994年由Friend等[4]在小鼠胸腺基质细胞中发现的,是IL-7中的细胞因子,可以刺激Th2细胞反应,参与炎症反应过程。近年TSLP在感染、变态反应性疾病及肿瘤等多种疾病中受到广泛关注,有研究发现在大鼠脓毒症的发生发展过程中,TSLP可以介导宿主骨髓细胞产生前炎细胞因子引起全身炎症反应失调,下调TSLP作用可以改善脓毒症的急性炎症反应,减少继发的多器官衰竭[5-7]。人外周血……
